1. Prescott, Sara L, Umans, Benjamin D, Williams, Erika K, Brust, Rachael D, Liberles, Stephen D. 2020. An Airway Protection Program Revealed by Sweeping Genetic Control of Vagal Afferents. In Cell, 181, 574-589.e14. doi:10.1016/j.cell.2020.03.004. https://pubmed.ncbi.nlm.nih.gov/32259485/
2. Hua, Yinggang, Liu, Yanling, Li, Long, Liu, Guoyan. 2023. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation. In Open life sciences, 18, 20220078. doi:10.1515/biol-2022-0078. https://pubmed.ncbi.nlm.nih.gov/36879646/
3. Tan, Yiao, Zhang, Tengyue, Zhou, Linyu, Liu, Shuhan, Liang, Chaozhao. 2019. MiR-34b-3p Represses the Multidrug-Chemoresistance of Bladder Cancer Cells by Regulating the CCND2 and P2RY1 Genes. In Medical science monitor : international medical journal of experimental and clinical research, 25, 1323-1335. doi:10.12659/MSM.913746. https://pubmed.ncbi.nlm.nih.gov/30778022/
4. Ueda, Yu, Li, Ronald H L, Nguyen, Nghi, Court, Michael H, Stern, Joshua A. 2021. A genetic polymorphism in P2RY1 impacts response to clopidogrel in cats with hypertrophic cardiomyopathy. In Scientific reports, 11, 12522. doi:10.1038/s41598-021-91372-3. https://pubmed.ncbi.nlm.nih.gov/34131167/
5. Timur, A A, Murugesan, G, Zhang, L, Bhatt, D L, Kottke-Marchant, K. 2012. P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. In International journal of laboratory hematology, 34, 473-83. doi:10.1111/j.1751-553X.2012.01420.x. https://pubmed.ncbi.nlm.nih.gov/22574824/
6. Läer, Katharina, Vennemann, Marielle, Rothämel, Thomas, Klintschar, Michael. 2013. Association between polymorphisms in the P2RY1 and SSTR2 genes and sudden infant death syndrome. In International journal of legal medicine, 127, 1087-91. doi:10.1007/s00414-013-0887-7. https://pubmed.ncbi.nlm.nih.gov/23828624/